Trial Profile
Analysis of the stratum corneum structure in the patients taking erlotinib -Towards the investigation of the mechanism of skin rash by the development of erlotinib administration
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2020
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 27 May 2016 New trial record